Literature DB >> 17412745

Facilitating and understanding the family's choice of injection device for growth hormone therapy by using conjoint analysis.

S F Ahmed1, W A Smith, C Blamires.   

Abstract

BACKGROUND: Conjoint analysis involves the measurement of consumer preferences between choice alternatives. AIMS AND
OBJECTIVES: To investigate the use of conjoint analysis in facilitating and understanding choice of growth hormone injection devices. METHOD AND
SUBJECTS: 56 patients and their parents participated in an electronic, computer-based interview. The interview took a median time of 18 min (range 12-30) and allowed an immediate matching of injection devices to the family's preferences.
RESULTS: Amongst the key drivers of choice, lack of bruising was rated highest and designated an index of 100. Compared to this, the remaining attributes in order of desirability were: auto-injector (98), lack of pain (93), lightweight (88), silent (82), ready-mixed (77), ease of holding (69), telephone helpline (66), needle-free (62), small size (60), nurse support (47), hidden needle (45), stored in fridge (13) and home delivery (6). Out of the 17 families who had already chosen a device previously by discussion with the clinic nurse, the computer model placed their device either as first or second out of seven devices tested.
CONCLUSION: Adaptive or interactive conjoint analysis applied at the patient level can facilitate the choice-making process whilst providing an insight into the relative importance of the key features that influence choice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17412745     DOI: 10.1136/adc.2006.105353

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

1.  A discrete choice conjoint experiment to evaluate parent preferences for treatment of young, medication naive children with ADHD.

Authors:  Daniel A Waschbusch; Charles E Cunningham; William E Pelham; Heather L Rimas; Andrew R Greiner; Elizabeth M Gnagy; James Waxmonsky; Gregory A Fabiano; Jessica A Robb; Lisa Burrows-Maclean; Mindy Scime; Martin T Hoffman
Journal:  J Clin Child Adolesc Psychol       Date:  2011

2.  Methodologic evaluation of adaptive conjoint analysis to assess patient preferences: an application in oncology.

Authors:  Arwen H Pieterse; Anne M Stiggelbout; Corrie A M Marijnen
Journal:  Health Expect       Date:  2010-12       Impact factor: 3.377

3.  Multi-criteria clinical decision support: A primer on the use of multiple criteria decision making methods to promote evidence-based, patient-centered healthcare.

Authors:  James G Dolan
Journal:  Patient       Date:  2010       Impact factor: 3.883

4.  Modeling the information preferences of parents of children with mental health problems: a discrete choice conjoint experiment.

Authors:  Charles E Cunningham; Ken Deal; Heather Rimas; Don H Buchanan; Michelle Gold; Katherine Sdao-Jarvie; Michael Boyle
Journal:  J Abnorm Child Psychol       Date:  2008-05-15

Review 5.  Discrete choice experiments in health economics: a review of the literature.

Authors:  Michael D Clark; Domino Determann; Stavros Petrou; Domenico Moro; Esther W de Bekker-Grob
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

6.  Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review.

Authors:  Christina Southern Reh; Mitchell E Geffner
Journal:  Clin Pharmacol       Date:  2010-06-01

7.  Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use.

Authors:  Anita Hokken-Koelega; Alexandra Keller; Viatcheslav Rakov; Stefan Kipper; Jovanna Dahlgren
Journal:  ISRN Endocrinol       Date:  2011-09-20

8.  Acceptability of the reusable SurePal™ self-injection device for Omnitrope(®) among pediatric patients: results from a questionnaire-based, cross-sectional, multicenter observational study.

Authors:  Carl-Joachim Partsch; Dirk Schnabel; Sarah Ehtisham; Helen C Johnstone; Markus Zabransky; Wieland Kiess
Journal:  Med Devices (Auckl)       Date:  2015-09-15

9.  Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study.

Authors:  Robert Rapaport; Paul Saenger; Heinrich Schmidt; Yukihiro Hasegawa; Michel Colle; Sandro Loche; Sandra Marcantonio; Walter Bonfig; Markus Zabransky; Fima Lifshitz
Journal:  Med Devices (Auckl)       Date:  2013-09-02

Review 10.  A Systematic Review of Patients' Perspectives on the Subcutaneous Route of Medication Administration.

Authors:  Colin H Ridyard; Dalia M M Dawoud; Lorna V Tuersley; Dyfrig A Hughes
Journal:  Patient       Date:  2016-08       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.